Skip to content
Dx

ICD-10-CM 2027 diagnosis code

H30.142Acute posterior multifocal placoid pigment epitheliopathy, left eye

✓ Billable / specificCC — complication/comorbidity

H30.142 is a valid, billable ICD-10-CM code for acute posterior multifocal placoid pigment epitheliopathy, left eye. It can be reported on claims for dates of service from October 1, 2026 – September 30, 2027.Short description: Acute post multifoc placoid pigment epitheliopathy, left eye

Code unchanged since ICD-10-CM took effect on October 1, 2015. Source: official FY2027 ICD-10-CM release from CDC/NCHS and CMS. Page updated September 29, 2026. About our data

About H30.142

H30.142 is the ICD-10-CM diagnosis code for acute posterior multifocal placoid pigment epitheliopathy, left eye. It belongs to category H30 (chorioretinal inflammation), block H30-H36 (disorders of choroid and retina) and chapter 7 (diseases of the eye and adnexa). It is billable, so it can be reported on its own for dates of service from October 1, 2026 through September 30, 2027.

Within H30.14 (acute posterior multifocal placoid pigment epitheliopathy), H30.142 is specifically for acute posterior multifocal placoid pigment epitheliopathy, left eye. Related codes cover right eye (H30.141), bilateral (H30.143) and unspecified eye (H30.149).

As a secondary diagnosis it is a CC (complication or comorbidity), which can move an inpatient stay into the "with CC" MS-DRG of its family, unless the principal diagnosis excludes it.

In MS-DRG v44.0, it is part of the grouping logic for DRG 124 (Other Disorders of the Eye with MCC or Thrombolytic Agent, relative weight 1.2471) and DRG 125 (Other Disorders of the Eye without MCC, relative weight 0.7702), in MDC 02 (Diseases and Disorders of the Eye), as a principal or secondary diagnosis. The DRG a claim lands in depends on the principal diagnosis, procedures and any CC/MCC secondary diagnoses.

It has been part of ICD-10-CM since the code set took effect on October 1, 2015 and hasn't changed since.

Before ICD-10, this condition was coded in ICD-9-CM as 363.15 (disseminated retinitis and retinochoroiditis, pigment epitheliopathy).

Notes that apply from higher levels

Instructions written at a parent level also apply to H30.142.

› From H30.1 Disseminated chorioretinal inflammation
Excludes2

Broader instructions also apply from Chapter 7: Diseases of the eye and adnexa.

MS-DRG v44.0 grouping

All DRGs →

Inpatient MS-DRGs this diagnosis can group to, as the principal or a secondary diagnosis, depending on the rest of the claim.

ICD-9-CM equivalent

Converter →
  • 363.15Disseminated retinitis and retinochoroiditis, pigment epitheliopathyapproximate

From the CMS 2018 General Equivalence Mappings (GEMs), the final GEMs release.

Code history

  1. 2016
  2. 2017
  3. 2018
  4. 2019
  5. 2020
  6. 2021
  7. 2022
  8. 2023
  9. 2024
  10. 2025
  11. 2026
  12. 2027
  • FY2016 (effective 10/1/2015): Added (first year of ICD-10-CM)
  • No changes since FY2016.

Common questions about H30.142

Is H30.142 billable?

Yes. H30.142 is a billable/specific ICD-10-CM code valid for FY2027 (October 1, 2026 – September 30, 2027).

Can H30.142 be used as a principal diagnosis?

Yes. The Medicare Code Editor doesn't restrict H30.142 as a principal diagnosis.

Is H30.142 a CC or MCC?

H30.142 is a CC (complication or comorbidity) under MS-DRG v44.0, unless excluded by the principal diagnosis.

What DRG does H30.142 group to?

H30.142 is used in the MS-DRG v44.0 logic for MS-DRG 124 (Other Disorders of the Eye with MCC or Thrombolytic Agent) and MS-DRG 125 (Other Disorders of the Eye without MCC). Which one applies depends on whether it is the principal diagnosis and on the rest of the claim.

What is the ICD-9 code for H30.142?

The CMS General Equivalence Mappings map H30.142 to ICD-9-CM 363.15.